Observational studyAnnals of the rheumatic diseases2017

Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs.

A Strangfeld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.